Literature DB >> 28469533

Effect of a Pediatric Prescription Medication Discharge Program on Reducing Hospital Readmission Rates.

Laura A Leathers, Kristy L Brittain, Kelly Crowley.   

Abstract

OBJECTIVES: To evaluate the pediatric prescription medication discharge delivery and counseling program, implemented at an 186-bed children's hospital integrated within a larger academic medical center, and its effectiveness on reducing hospital readmissions.
METHODS: This study was a retrospective chart review of existing data in the electronic medical record from patients <21 years of age who were discharged from our institution between September 1, 2014, and November 30, 2014. Patients who participated in the pediatric discharge program were compared to non-participants. The primary objective was to determine if the patient was readmitted within 30 days. Secondary objectives included time until readmission, diagnosis at discharge, and hospital unit at discharge.
RESULTS: In total, 1804 patients were assessed. After exclusions, 932 subjects were included in the analysis. In total, 393 (42.2%) patients participated in the pediatric medication discharge and counseling program, and 539 did not participate. Of the patients who participated in the program, 52 were readmitted within 30 days (13.2%), compared with 67 patients (12.4%) who did not participate in the discharge program, p = 0.717. Patients with the diagnoses of malignancy and kidney injury were more likely to be readmitted within this time frame, and those with the diagnoses of heart defects or cardiology disorders and malignancy were more likely to participate in the pediatric prescription medication discharge program.
CONCLUSION: Participation in the pediatric discharge medication delivery and counseling program did not reduce hospital readmission rate within 30 days.

Entities:  

Keywords:  medication counseling; patient readmission; pediatrics; pharmaceutical services; pharmacist

Year:  2017        PMID: 28469533      PMCID: PMC5410864          DOI: 10.5863/1551-6776-22.2.94

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  6 in total

1.  Unplanned readmissions to acute care from a pediatric postacute care hospital: incidence, clinical reasons, and predictive factors.

Authors:  Jane E O'Brien; Helene M Dumas; Carol M Nash; Rania Mekary
Journal:  Hosp Pediatr       Date:  2015-03

2.  Postdischarge interventions by pharmacists and impact on hospital readmission rates.

Authors:  Jessica M Bellone; Jamie C Barner; Debra A Lopez
Journal:  J Am Pharm Assoc (2003)       Date:  2012 May-Jun

3.  Hospital readmission in children with complex chronic conditions discharged from subacute care.

Authors:  Valerie Jurgens; Michael C Spaeder; Padmaja Pavuluri; Zev Waldman
Journal:  Hosp Pediatr       Date:  2014-05

4.  Evaluation of a pharmacy-driven inpatient discharge counseling service: impact on 30-day readmission rates.

Authors:  Kimberly L Still; Azizza K Davis; Allison A Chilipko; Aroonjit Jenkosol; Daryn K Norwood
Journal:  Consult Pharm       Date:  2013-12

5.  Impact of pharmacist discharge medication therapy counseling and disease state education: Pharmacist Assisting at Routine Medical Discharge (project PhARMD).

Authors:  Preeyaporn Sarangarm; Matthew S London; Stanley S Snowden; Thomas J Dilworth; Lisa R Koselke; Christian O Sanchez; Richard D'Angio; Gretchen Ray
Journal:  Am J Med Qual       Date:  2012-10-02       Impact factor: 1.852

6.  Pediatric readmission prevalence and variability across hospitals.

Authors:  Jay G Berry; Sara L Toomey; Alan M Zaslavsky; Ashish K Jha; Mari M Nakamura; David J Klein; Jeremy Y Feng; Shanna Shulman; Vincent W Chiang; Vincent K Chiang; William Kaplan; Matt Hall; Mark A Schuster
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

  6 in total
  1 in total

1.  Descriptive study of discharge medications in pediatric patients.

Authors:  Thao T Nguyen; Erica Bergeron; Teresa V Lewis; Jamie L Miller; Tracy M Hagemann; Stephen Neely; Peter N Johnson
Journal:  SAGE Open Med       Date:  2020-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.